| [1] |
Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2014, 35(39):2733-2779.
|
| [2] |
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) [J]. Eur Heart J, 2015, 36(41):2793-2867.
|
| [3] |
Hershberger RE, Cowan J, Morales A, et al. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy [J]. Circ Heart Fail, 2009, 2(3):253-261.
|
| [4] |
Parato VM, Antoncecchi V, Sozzi F, et al. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy [J]. Cardiovasc Ultrasound, 2016, 14(1):30.
|
| [5] |
Zou Y, Wang J, Liu X, et al. Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy [J]. Mol Biol Rep, 2013, 40(6):3969-3976.
|
| [6] |
Maron BJ. Cardiology patient pages. Hypertrophic cardiomyopathy [J]. Circulation, 2002, 106(19):2419-2421.
|
| [7] |
Losi MA, Nistri S, Galderisi M, et al. Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment [J]. Cardiovasc Ultrasound, 2010, 8:7.
|
| [8] |
Luckie M, Khattar RS. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques [J]. Minerva Cardioangiol, 2011, 59(6):581-589.
|
| [9] |
Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2014, 35(39):2733-2779.
|
| [10] |
宋雷，徐荣，吴格茹, 等. 肌球蛋白重链基因Arg663Cys和Arg663His突变基因型与家族性肥厚型心肌病表型关系研究 [J]. 中华心血管病杂志, 2002, 30(3):131-135.
|
| [11] |
曾杰，李靖. 基因突变阳性肥厚型心肌病患者超声心动图表现初步探讨 [J]. 医学影像学杂志, 2008, 18(2):121-124.
|
| [12] |
Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients [J]. Am J Cardiol, 1981, 48(3):418-428.
|
| [13] |
王曙霞，邹玉宝，傅春燕, 等. 心脏型肌钙蛋白Ⅰ基因4693 C/T突变导致家族性心尖部肥厚型心肌病 [J]. 中国分子心脏病学杂志, 2006, 6(5):253-256.
|
| [14] |
Elliott K, Watkins H, Redwood CS. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy [J]. J Biol Chem, 2000, 275(29):22069-22074.
|
| [15] |
曲辅政，孙经武，孙晓健, 等. 中国北方汉族家族性肥厚型心肌病人群MYH7基因Arg694Leu突变分析 [J]. 中国心血管病研究, 2011, 9(8):592-595.
|
| [16] |
宋雷，黄晓红，惠汝太, 等. 心肌球蛋白重链基因Arg719G1n突变与家族性肥厚型心肌病[J]. 中华心血管病杂志, 2001, 29(6):348-352.
|
| [17] |
王虎，邹玉宝，王继征, 等. MYBPC3基因G12101A和MYH7基因G15391A突变与肥厚型心肌病临床表型 [J]. 中华心血管病杂志, 2008, 36(12):1059-1062.
|
| [18] |
孔德华，王爱玲，陈多学, 等. 家族性肥厚型心肌病患者MYBPC3基因突变筛查 [J]. 临床心血管病杂志, 2010, 26(2):93-96.
|
| [19] |
Rayment I, Holden HM, Sellers JR, et al. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy [J]. Proc Natl Acad Sci U S A, 1995, 92(9):3864-3868.
|
| [20] |
Oliva-Sandoval MJ, Ruiz-Espejo F, Monserrat L, et al. Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3 [J]. Heart, 2010, 96(24):1980-1984.
|
| [21] |
Ehlermann P, Weichenhan D, Zehelein J, et al. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene [J]. BMC Med Genet, 2008, 9:95.
|
| [22] |
赵蓓，李娟，杨帆, 等. 心肌肌球蛋白结合蛋白C基因双突变致家族性肥厚型心肌病的相关表型分析 [J]. 中南大学学报(医学版), 2013, 38(1):14-19.
|
| [23] |
王虎，邹玉宝，宋雷, 等. 心脏肌球蛋白重链基因c.1273G>A突变与肥厚型心肌病的关联分析 [J]. 遗传, 2009, 31(5):485-488.
|
| [24] |
Maron BJ, Maron MS, Semsarian C. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors [J]. Heart Rhythm, 2012, 9(1):57-63.
|
| [25] |
Niimura H, Patton KK, Mckenna WJ, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly [J]. Circulation, 2002, 105(4):446-451.
|
| [26] |
Emrahi L, Tabrizi MT, Gharehsouran J, et al. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran [J]. Clin Lab, 2016, 62(5):757-764.
|
| [27] |
Smith N, Steeds R, Masani N, et al. A systematic approach to echocardiography in hypertrophic cardiomyopathy: a guideline protocol from the British Society of Echocardiography [J]. Echo Res Pract, 2015, 2(1):G1-G7.
|
| [28] |
Watkins H, Mckenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy [J]. N Engl J Med, 1995, 332(16):1058-1064.
|
| [29] |
韩智红，宋月洁，姜腾勇, 等. 肥厚型心肌病患者肌钙蛋白T基因突变的研究 [J]. 中华实用诊断与治疗杂志, 2014, 28(1):27-29.
|
| [30] |
Seidman CE, Seidman JG. Molecular genetic studies of familial hypertrophic cardiomyopathy [J]. Basic Res Cardiol, 1998, 93 Suppl 3:13-16.
|
| [31] |
Li Q, Gruner C, Chan RH, et al. Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events [J]. Circ Cardiovasc Genet, 2014, 7(4):416-422.
|
| [32] |
Marsiglia JD, Credidio FL, de Oliveira TG, et al. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy [J]. Am Heart J, 2013, 166(4):775-782.
|
| [33] |
施鑫，周炳元，赵彩明, 等. 家族性肥厚型心肌病TNNI3基因突变研究 [J]. 江苏医药, 2016, 42(1):41-43.
|
| [34] |
Doolan A, Tebo M, Ingles J, et al. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences [J]. J Mol Cell Cardiol, 2005, 38(2):387-393.
|
| [35] |
刘杰，刘文玲，胡大一, 等. 中国大样本队列肥厚型心肌病患者基因突变谱及其临床相关性 [J]. 中华心血管病杂志, 2015, 43(8):682-689.
|
| [36] |
Tomasov P, Minarik M, Zemanek D, et al. Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy [J]. Folia Biol (Praha), 2014, 60(1):28-34.
|